Breast Cancer
New findings from K.P. Garnockjones and co-researchers in the area of breast cancer described
Published in Women's Health Weekly, April 8th, 2010
"Trastuzumab (Herceptin ®) is a humanized IgG(1) kappa monoclonal antibody, specifically targeted against the extracellular domain of the human epidermal growth factor receptor 2 (HER2), and is indicated for the treatment of HER2-positive early or metastatic breast cancer. This review discusses the available data regarding its use in early breast cancer," scientists in Auckland, New Zealand report.
"Trastuzumab, when administered concurrently with chemotherapy regimens, consistently prolonged disease-free survival (primary endpoint) and overall survival (secondary endpoint) in patients with HER2-positive early breast cancer in well designed trials; Studies...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- ECCO-the European CanCer Organisation
Worse breast cancer outcomes for women from poorer backgrounds are not due to late diagnosis alone - Journal of the National Cancer Institute
Rare ATM gene mutations, plus radiation, may increase risk of a second breast cancer - University of California - San Francisco
Benefits of osteoporosis treatments outweigh possible risk of rare femoral fractures - Breast Cancer
Investigators at University of Washington, Nursing Department publish new data on breast cancer - Breast Cancer
New breast cancer research from Norwegian University Science & Technology described - Breast Cancer
New findings reported from G.L. Ma and co-authors describe advances in breast cancer - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
